These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15822043)

  • 21. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.
    Katsinelos P; Kountouras J; Chatzis J; Christodoulou K; Paroutoglou G; Mimidis K; Beltsis A; Zavos C
    Gastrointest Endosc; 2005 Mar; 61(3):407-15. PubMed ID: 15758912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
    Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
    Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
    Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
    Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.
    Katsinelos P; Kountouras J; Paroutoglou G; Beltsis A; Mimidis K; Zavos C
    Gastrointest Endosc; 2005 Jul; 62(1):105-11. PubMed ID: 15990827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.
    Arvanitidis D; Anagnostopoulos GK; Giannopoulos D; Pantes A; Agaritsi R; Margantinis G; Tsiakos S; Sakorafas G; Kostopoulos P
    J Gastroenterol Hepatol; 2004 Mar; 19(3):278-82. PubMed ID: 14748874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS; Wu SM; Zhang XW; Ge ZZ
    Braz J Med Biol Res; 2006 Jan; 39(1):85-90. PubMed ID: 16400468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy.
    Uemura K; Murakami Y; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2008 Oct; 98(5):309-13. PubMed ID: 18548482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
    Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
    Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
    Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
    Sand J; Nordback I
    Digestion; 1993; 54(2):105-11. PubMed ID: 8319838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.